Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19
Article in Microbial Cell Factories (February 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Microbial Cell Factories (February 2024)
Article in Applied Microbiology and Biotechnology (January 2024)
Article in Fish & Shellfish Immunology (January 2024)